Further investment in our production capacity

The board of directors of the CPH holding group decided at the last meeting in Luzern to invest an additional 13.5 Mill. Euro. This investment completes the production trains 12 and 13 in the FDA approved facilities of CU Chemie Uetikon Lahr.

This expansion will provide Chemie Uetikon with an additional capacity to fulfil the growing demand of our customers. Furthermore, it has been decided to add a low temperature reaction unit in this state-of-the-art production facility to be able to produce advanced intermediates and to perform reactions like Suzuki couplings and Lithiations.